The company
Niagen Bioscience, Inc.
NAGE · Nasdaq
NAGE stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 31.1% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 31% -7 in 4 wk
- Insider buys, 12 months
- $46K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 131 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 4,184,659$13.3M | +313,040+8.1% |
| SteelPeak Wealth, LLCadded · filed 13 Jul 2026 | 3,500,129$11.2M | +127,129+3.8% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 2,147,018$6.8M | -2,259−0.1% |
| Qube Research & Technologies Ltdreduced · filed 14 Aug 2026 | 1,625,016$5.2M | -89,623−5.2% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,478,603$4.7M | +133,682+9.9% |
| UBS Group AGreduced · filed 13 Aug 2026 | 1,283,296$4.1M | -122,235−8.7% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 1,262,743$4.0M | +10,784+0.9% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIPreduced · filed 13 Aug 2026 | 1,171,215$3.7M | -1,207,222−50.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 1,166,233$3.7M | -55,261−4.5% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 1,082,752$3.5M | -1,813−0.2% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.